The best of STAT+ 🏅 April subscriber benefits

Enjoy discounts on STAT Reports and events, free access to data tools like our CRISPR TRACKR, and daily coverage of the life sciences. ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

www.statnews.com/stat-plus Subscribe to STAT+ and access exclusive benefits this month When you're a STAT+ subscriber, you get to enjoy perks like discounts on our STAT Reports and events, free access to premium data tools like our CRISPR TRACKR, as well as in-depth daily coverage and analysis of the life sciences. Subscribe now and get your first 3 months for $30 to celebrate National Public Health Week. SUBSCRIBE STAT Breakthrough Summit Date: May 3–4, 2023 Location: San Francisco, CA / Virtual What does biotech look like after the collapse of SVB? Can CRISPR become an accessible technology? Do viruses cause Alzheimer's? Answer these questions and more with STAT reporters and industry leaders. STAT+ subscribers unlock a pass at 20% off by using their login credentials. Learn More Our Latest STAT Report on Treating Depression STAT's latest report on depression treatment details the challenges, possibilities, and frontrunners in the race to remake treatment of the world's most common mental health problem. Written by Ben Carey, former human behavior reporter for The New York Times. STAT+ subscribers can get a 20% discount on all STAT Reports. Purchase Breakout Stars in Science Date: April 27, 2023 at 1:00pm ET Location: Virtual Meet heroes of science and medicine who are in the midst of launching their careers, bringing innovation and inspiration to their fields. You'll hear from a professor of neurology, a director of social medicine, and more. Sign Up RYAN PIERSE/GETTY IMAGES 2023 Q2 Biotech Scorecard Every quarter STAT releases a biotech scorecard — our regular ledger of stock-moving biotech events compiled by STAT's national biotech columnist, Adam Feuerstein. Subscribe to STAT+ to read the full scorecard and learn more about the important, mid-year events to start thinking about. READ MORE Explore the 2023 STATUS List Learn more about the 46 inspirational leaders who are mapping the future of health, medicine, and the life sciences. Explore the STATUS List and read their stories, celebrate their work, and gain greater insight about those who are determining our future. Learn More STAT+ Reads Check out our recent top stories: CRISPR patent fight redux? A new battle is brewing among biotechs over next-gen gene-editing tools by Jason Mast, Allison DeAngelis, and Megan Molteni Denied by AI: How Medicare Advantage plans use algorithms to cut off care for seniors in need by Casey Ross and Bob Herman New weight loss drugs are changing the narrative on obesity, with a push from pharma by Elaine Chen and Matthew Herper SVB, biotech's bank of choice, just failed. It could have ripple effects by Adam Feuerstein, Damian Garde, and Allison DeAngelis READ MORE  Tuesday, April 4, 2023       1 Exchange Place, Boston, MA 02109 ©2023, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us